Skip to main content
. 2003 Dec;41(12):5729–5731. doi: 10.1128/JCM.41.12.5729-5731.2003

TABLE 2.

In vitro activity of caspofungin against 351 clinical isolates of Candida spp. resistant to fluconazolea

Species No. of isolates tested Cumulative % of isolates susceptible at MIC (μg/ml)b of:
0.03 0.06 0.12 0.25 0.5 1 2 4
C. albicans 47 0 0 30 66 74 96 98 100
C. glabrata 121 1 45 68 82 95 100
C. krusei 171 38 38 38 39 47 88 99
Candida spp.c 12 25 25 42 58 67 67 92 100
All species 351 20 35 47 58 68 92 99 100
a

Fluconazole resistance was determined by NCCLS M27-A2 broth microdilution and fluconazole interpretive criteria (resistance MIC, ≥64 μg/ml).

b

Caspofungin MICs were determined by the NCCLS M27-A2 broth microdilution method.

c

C. tropicalis (three isolates), C. guilliermondii (three isolates), C. parapsilosis (four isolates), C. lusitaniae (one isolate), and C. lipolytica (one isolate).